Table 1 Patient's characteristics before autologous haematopoietic stem cell transplantation.

Patient	Diagnosis	Age, sex	Organs involved, laboratory values, examinations	Treatment before HSCT	Months since diagnosis
1	Undifferentiated vasculitis	41, f	Kidney, active sediment, eye	Cyc, IV immunoglobulins	42
2	Behçet's disease	49, m	CNS involvement, fever, posterior uveitis	Cyc, steroids	84
3	Behçet's disease	32, m	Intracardial thrombus, pulmonalarterial aneurysma, polyarthritis	Cyc, MTX, steroids	63
4	Wegener's granulomatosis	46, f	Eye, nose, ANCA neg	Cyc	40
5	Wegener's granulomatosis	34, f	Lungs, sinus, kidney, c‐ANCA 1:320	Cyc 100 g, CSA, kidney transplantation	132
6	Cryoglobulinaemia	42, f	Skin vasculitis with ulcers, arthritis, cryoglobulins 5.9 mg/ml	Chlorambucil	36
7	Cryoglobulinaemia	57, m	Arthritis, polyneuropathy	aPBSCT 2 years earlier, data lost	33
8	Cryoglobulinaemia	30, m	GN, severe pulmonary hypertension, sys pap >60 mm Hg	Plasmapheresis, Cyc 18 g	41
9	Churg–Strauss angiitis	31, f	Kidney, lung, LN, eosinophils 2200/μl, ANCA neg	Cyc 10 g, INF, CSA, AZA, MTX	84
10	Takayasu arteritis	22, f	Aortitis (PET), ESR 75 mm/h	Cyc 2 g, infliximab, anakinra, MTX	40
11	Polychondritis	36, f	Aortitis, scleritis, cartilages, ESR 100 mm/h	Infliximab, Cyc 13 g, fludarabine rapamycin, MMF	114
12	Polyarteritis nodosa	41, m	Skin, heart, brain, kidney, ESR 60 mm/h	Cyc >100 g	60

ANCA, antineutrophil cytoplasmic antibody; aPBSCT, autologous peripheral blood stem cell transplantation; AZA, azathioprine; c‐ANCA, classical antineutrophil cytoplasmic antibody substitute circulating with classical; CNS, central nervous system; CSA, ciclosporin A; Cyc, cyclophosphamide; ESR, erythrocyte sedimentation rate; f, female; GN, glomerulonephritis; HSCT, haematopoietic stem cell transplantation; INF, interferon; IV, intravenous; LN, lymph nodes; m, male; MTX, methotrexate; neg, negative; PET, positron emission tomography; sys pap, systolic pulmonary arterial pressure.